The independent source for health policy research, polling, and news.
11,921-11,940 of 113,102 results
One study, published in Nature, offers details into the cytokine storms that overwhelm some covid patients. Another study, published in the journal BMJ, suggests that being infected with covid raises your risk of developing serious blood clots.
A sobering report from the National Academies of Sciences, Engineering and Medicine also suggests solutions for the "broken" U.S. nursing home health industry. The panel cited major problems around health care, staffing and facility finances that impact the 1.3 million Americans living and 3 million working in such facilities.
Many health care workers report trauma-like symptoms similar to combat veterans such as depression or a lower-quality of life, a study finds. NPR also reports on how people particularly vulnerable to covid are also traumatized.
Those who tested positive following the event — where high-profile government players and journalists mixed indoors, unmasked — include the U.S. attorney general, commerce secretary, the vice president's communications director, congressional lawmakers, and others. President Joe Biden did not attend.
The congressional deal to allocate $10 billion to sustain federal covid testing, treatment and vaccine measures has been held up indefinitely by a Republican push to tie it to a border-control policy. News outlets also report on the rabid fox that bit nine people near Capitol Hill.
The FDA's independent vaccine advisory panel met Wednesday to discuss how covid vaccines should be adjusted for future variants. Specific recommendations for next fall's shot may be put to a vote in May or June.
Today's early morning highlights from the major news organizations.
Editorial writers weigh in on these public health issues.
Opinion writers examine these covid issues.
An analysis of list prices of commonly prescribed drugs by Patients for Affordable Drugs found large price increases. In other news, Douglas Melton, one of the leading stem cell researchers in the world, is leaving Harvard University to join Vertex Pharmaceuticals to work on diabetes treatments.
Read recent commentaries about drug-cost issues.
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
A new report from the Commonwealth Fund provides a deep dive into how American women are let down by the health system, including that they're more likely to die from preventable causes than women in other wealthy countries, and over three times more likely to die during pregnancy.
In what supporters call a "parental rights" move, Ohio lawmakers introduced House Bill 616 — similar to a new Florida law designed to stymie educators discussing gender issues with young children. Meanwhile, the Texas Tribune reports on pushback on Texas' plan to pass similar legislation.
A report from the nonprofit Center for Countering Digital Hate says women "in the public eye" are being failed by Instagram, including the service not removing accounts aiming abuse at them.
Other big pharmacy chains have settled in Florida, but Walgreens will face a jury over its opioid distribution. Other news is on opioids, and on pot distribution in the nation's capital.
In other news, about 28% of young American people aged 12 to 19 show signs of prediabetes; a science team has found microplastics in live human lung tissue for the first time; and a California startup is trying to convert pollutant gasses into a new kind of artificial meat.
A California state court rules a hospital can be held responsible for sexual abuse of a patient by an employee. In other hospital industry news, the Health and Human Services Department wants to know how health care organizations implement security practices to protect patients' information.
Oklahoma's Republican governor has said he will sign any anti-abortion bill sent to him. This one makes it a felony to perform an abortion. Idaho and Iowa also ready anti-abortion measures.
The dramatic rise of omicron covid subvariant BA.2 is seen in data from the Centers for Disease Control and Prevention. Separately, since GlaxoSmithKline's covid drug sotrovimab is known to be ineffective in treating this subvariant, the FDA has deauthorized its use.
© 2026 KFF